Global Tumor Liquid Biopsy Kit Market Growth 2026-2032
The global Tumor Liquid Biopsy Kit market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Liquid biopsy test kits are typically used to test liquid samples from an organism, such as blood, urine, or other body fluids, to obtain information about health status, disease diagnosis, or treatment response. These test kits contain specific reagents and kit components for performing specific biochemical, immunological, or molecular biology experiments.
United States market for Tumor Liquid Biopsy Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Tumor Liquid Biopsy Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Tumor Liquid Biopsy Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Tumor Liquid Biopsy Kit players cover Biocept, Qiagen, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Tumor Liquid Biopsy Kit Industry Forecast? looks at past sales and reviews total world Tumor Liquid Biopsy Kit sales in 2025, providing a comprehensive analysis by region and market sector of projected Tumor Liquid Biopsy Kit sales for 2026 through 2032. With Tumor Liquid Biopsy Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Liquid Biopsy Kit industry.
This Insight Report provides a comprehensive analysis of the global Tumor Liquid Biopsy Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Liquid Biopsy Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tumor Liquid Biopsy Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Liquid Biopsy Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Liquid Biopsy Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Liquid Biopsy Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Liquid biopsy test kits are typically used to test liquid samples from an organism, such as blood, urine, or other body fluids, to obtain information about health status, disease diagnosis, or treatment response. These test kits contain specific reagents and kit components for performing specific biochemical, immunological, or molecular biology experiments.
United States market for Tumor Liquid Biopsy Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Tumor Liquid Biopsy Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Tumor Liquid Biopsy Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Tumor Liquid Biopsy Kit players cover Biocept, Qiagen, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Tumor Liquid Biopsy Kit Industry Forecast? looks at past sales and reviews total world Tumor Liquid Biopsy Kit sales in 2025, providing a comprehensive analysis by region and market sector of projected Tumor Liquid Biopsy Kit sales for 2026 through 2032. With Tumor Liquid Biopsy Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Liquid Biopsy Kit industry.
This Insight Report provides a comprehensive analysis of the global Tumor Liquid Biopsy Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Liquid Biopsy Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tumor Liquid Biopsy Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Liquid Biopsy Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Liquid Biopsy Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Liquid Biopsy Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Blood Samples
- Urine Samples
- NGS
- Others
- Solid Tumor
- Blood Cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biocept
- Qiagen
- Roche Diagnostics
- Bio-Rad Laboratories
- Myriad Genetics
- Menarini-Silicon Biosystems
- Cardiff Oncology
- Guardant Health
- Mdxhealth
- Genomic Health(Exact Sciences?
- NeoGenomics
- Thermo Fisher Scientific
- Illumina
- Amoy Diagnostics
- Burning Rock Dx
- Genetron
- BGI
- Novogene
- Agena Bioscience(Mesa Labs, Inc.)
- What is the 10-year outlook for the global Tumor Liquid Biopsy Kit market?
- What factors are driving Tumor Liquid Biopsy Kit market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Tumor Liquid Biopsy Kit market opportunities vary by end market size?
- How does Tumor Liquid Biopsy Kit break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor Liquid Biopsy Kit Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Tumor Liquid Biopsy Kit by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Tumor Liquid Biopsy Kit by Country/Region, 2021, 2025 & 2032
2.2 Tumor Liquid Biopsy Kit Segment by Type
2.2.1 Blood Samples
2.2.2 Urine Samples
2.2.3 NGS
2.2.4 Others
2.2.5 Tumor Liquid Biopsy Kit Sales by Type
2.2.5.1 Global Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
2.2.5.2 Global Tumor Liquid Biopsy Kit Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Tumor Liquid Biopsy Kit Sale Price by Type (2021-2026)
2.3 Tumor Liquid Biopsy Kit Segment by Application
2.3.1 Solid Tumor
2.3.2 Blood Cancer
2.3.3 Tumor Liquid Biopsy Kit Sales by Application
2.3.3.1 Global Tumor Liquid Biopsy Kit Sale Market Share by Application (2021-2026)
2.3.3.2 Global Tumor Liquid Biopsy Kit Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Tumor Liquid Biopsy Kit Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Tumor Liquid Biopsy Kit Breakdown Data by Company
3.1.1 Global Tumor Liquid Biopsy Kit Annual Sales by Company (2021-2026)
3.1.2 Global Tumor Liquid Biopsy Kit Sales Market Share by Company (2021-2026)
3.2 Global Tumor Liquid Biopsy Kit Annual Revenue by Company (2021-2026)
3.2.1 Global Tumor Liquid Biopsy Kit Revenue by Company (2021-2026)
3.2.2 Global Tumor Liquid Biopsy Kit Revenue Market Share by Company (2021-2026)
3.3 Global Tumor Liquid Biopsy Kit Sale Price by Company
3.4 Key Manufacturers Tumor Liquid Biopsy Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tumor Liquid Biopsy Kit Product Location Distribution
3.4.2 Players Tumor Liquid Biopsy Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TUMOR LIQUID BIOPSY KIT BY GEOGRAPHIC REGION
4.1 World Historic Tumor Liquid Biopsy Kit Market Size by Geographic Region (2021-2026)
4.1.1 Global Tumor Liquid Biopsy Kit Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Tumor Liquid Biopsy Kit Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Tumor Liquid Biopsy Kit Market Size by Country/Region (2021-2026)
4.2.1 Global Tumor Liquid Biopsy Kit Annual Sales by Country/Region (2021-2026)
4.2.2 Global Tumor Liquid Biopsy Kit Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tumor Liquid Biopsy Kit Sales Growth
4.4 APAC Tumor Liquid Biopsy Kit Sales Growth
4.5 Europe Tumor Liquid Biopsy Kit Sales Growth
4.6 Middle East & Africa Tumor Liquid Biopsy Kit Sales Growth
5 AMERICAS
5.1 Americas Tumor Liquid Biopsy Kit Sales by Country
5.1.1 Americas Tumor Liquid Biopsy Kit Sales by Country (2021-2026)
5.1.2 Americas Tumor Liquid Biopsy Kit Revenue by Country (2021-2026)
5.2 Americas Tumor Liquid Biopsy Kit Sales by Type (2021-2026)
5.3 Americas Tumor Liquid Biopsy Kit Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Liquid Biopsy Kit Sales by Region
6.1.1 APAC Tumor Liquid Biopsy Kit Sales by Region (2021-2026)
6.1.2 APAC Tumor Liquid Biopsy Kit Revenue by Region (2021-2026)
6.2 APAC Tumor Liquid Biopsy Kit Sales by Type (2021-2026)
6.3 APAC Tumor Liquid Biopsy Kit Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tumor Liquid Biopsy Kit by Country
7.1.1 Europe Tumor Liquid Biopsy Kit Sales by Country (2021-2026)
7.1.2 Europe Tumor Liquid Biopsy Kit Revenue by Country (2021-2026)
7.2 Europe Tumor Liquid Biopsy Kit Sales by Type (2021-2026)
7.3 Europe Tumor Liquid Biopsy Kit Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor Liquid Biopsy Kit by Country
8.1.1 Middle East & Africa Tumor Liquid Biopsy Kit Sales by Country (2021-2026)
8.1.2 Middle East & Africa Tumor Liquid Biopsy Kit Revenue by Country (2021-2026)
8.2 Middle East & Africa Tumor Liquid Biopsy Kit Sales by Type (2021-2026)
8.3 Middle East & Africa Tumor Liquid Biopsy Kit Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tumor Liquid Biopsy Kit
10.3 Manufacturing Process Analysis of Tumor Liquid Biopsy Kit
10.4 Industry Chain Structure of Tumor Liquid Biopsy Kit
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tumor Liquid Biopsy Kit Distributors
11.3 Tumor Liquid Biopsy Kit Customer
12 WORLD FORECAST REVIEW FOR TUMOR LIQUID BIOPSY KIT BY GEOGRAPHIC REGION
12.1 Global Tumor Liquid Biopsy Kit Market Size Forecast by Region
12.1.1 Global Tumor Liquid Biopsy Kit Forecast by Region (2027-2032)
12.1.2 Global Tumor Liquid Biopsy Kit Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Tumor Liquid Biopsy Kit Forecast by Type (2027-2032)
12.7 Global Tumor Liquid Biopsy Kit Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Biocept
13.1.1 Biocept Company Information
13.1.2 Biocept Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.1.3 Biocept Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Biocept Main Business Overview
13.1.5 Biocept Latest Developments
13.2 Qiagen
13.2.1 Qiagen Company Information
13.2.2 Qiagen Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.2.3 Qiagen Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Qiagen Main Business Overview
13.2.5 Qiagen Latest Developments
13.3 Roche Diagnostics
13.3.1 Roche Diagnostics Company Information
13.3.2 Roche Diagnostics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.3.3 Roche Diagnostics Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Roche Diagnostics Main Business Overview
13.3.5 Roche Diagnostics Latest Developments
13.4 Bio-Rad Laboratories
13.4.1 Bio-Rad Laboratories Company Information
13.4.2 Bio-Rad Laboratories Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.4.3 Bio-Rad Laboratories Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bio-Rad Laboratories Main Business Overview
13.4.5 Bio-Rad Laboratories Latest Developments
13.5 Myriad Genetics
13.5.1 Myriad Genetics Company Information
13.5.2 Myriad Genetics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.5.3 Myriad Genetics Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Myriad Genetics Main Business Overview
13.5.5 Myriad Genetics Latest Developments
13.6 Menarini-Silicon Biosystems
13.6.1 Menarini-Silicon Biosystems Company Information
13.6.2 Menarini-Silicon Biosystems Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.6.3 Menarini-Silicon Biosystems Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Menarini-Silicon Biosystems Main Business Overview
13.6.5 Menarini-Silicon Biosystems Latest Developments
13.7 Cardiff Oncology
13.7.1 Cardiff Oncology Company Information
13.7.2 Cardiff Oncology Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.7.3 Cardiff Oncology Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cardiff Oncology Main Business Overview
13.7.5 Cardiff Oncology Latest Developments
13.8 Guardant Health
13.8.1 Guardant Health Company Information
13.8.2 Guardant Health Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.8.3 Guardant Health Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Guardant Health Main Business Overview
13.8.5 Guardant Health Latest Developments
13.9 Mdxhealth
13.9.1 Mdxhealth Company Information
13.9.2 Mdxhealth Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.9.3 Mdxhealth Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mdxhealth Main Business Overview
13.9.5 Mdxhealth Latest Developments
13.10 Genomic Health(Exact Sciences?
13.10.1 Genomic Health(Exact Sciences? Company Information
13.10.2 Genomic Health(Exact Sciences? Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.10.3 Genomic Health(Exact Sciences? Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Genomic Health(Exact Sciences? Main Business Overview
13.10.5 Genomic Health(Exact Sciences? Latest Developments
13.11 NeoGenomics
13.11.1 NeoGenomics Company Information
13.11.2 NeoGenomics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.11.3 NeoGenomics Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 NeoGenomics Main Business Overview
13.11.5 NeoGenomics Latest Developments
13.12 Thermo Fisher Scientific
13.12.1 Thermo Fisher Scientific Company Information
13.12.2 Thermo Fisher Scientific Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.12.3 Thermo Fisher Scientific Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Thermo Fisher Scientific Main Business Overview
13.12.5 Thermo Fisher Scientific Latest Developments
13.13 Illumina
13.13.1 Illumina Company Information
13.13.2 Illumina Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.13.3 Illumina Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Illumina Main Business Overview
13.13.5 Illumina Latest Developments
13.14 Amoy Diagnostics
13.14.1 Amoy Diagnostics Company Information
13.14.2 Amoy Diagnostics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.14.3 Amoy Diagnostics Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Amoy Diagnostics Main Business Overview
13.14.5 Amoy Diagnostics Latest Developments
13.15 Burning Rock Dx
13.15.1 Burning Rock Dx Company Information
13.15.2 Burning Rock Dx Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.15.3 Burning Rock Dx Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Burning Rock Dx Main Business Overview
13.15.5 Burning Rock Dx Latest Developments
13.16 Genetron
13.16.1 Genetron Company Information
13.16.2 Genetron Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.16.3 Genetron Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Genetron Main Business Overview
13.16.5 Genetron Latest Developments
13.17 BGI
13.17.1 BGI Company Information
13.17.2 BGI Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.17.3 BGI Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 BGI Main Business Overview
13.17.5 BGI Latest Developments
13.18 Novogene
13.18.1 Novogene Company Information
13.18.2 Novogene Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.18.3 Novogene Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Novogene Main Business Overview
13.18.5 Novogene Latest Developments
13.19 Agena Bioscience(Mesa Labs, Inc.)
13.19.1 Agena Bioscience(Mesa Labs, Inc.) Company Information
13.19.2 Agena Bioscience(Mesa Labs, Inc.) Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.19.3 Agena Bioscience(Mesa Labs, Inc.) Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Agena Bioscience(Mesa Labs, Inc.) Main Business Overview
13.19.5 Agena Bioscience(Mesa Labs, Inc.) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor Liquid Biopsy Kit Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Tumor Liquid Biopsy Kit by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Tumor Liquid Biopsy Kit by Country/Region, 2021, 2025 & 2032
2.2 Tumor Liquid Biopsy Kit Segment by Type
2.2.1 Blood Samples
2.2.2 Urine Samples
2.2.3 NGS
2.2.4 Others
2.2.5 Tumor Liquid Biopsy Kit Sales by Type
2.2.5.1 Global Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
2.2.5.2 Global Tumor Liquid Biopsy Kit Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Tumor Liquid Biopsy Kit Sale Price by Type (2021-2026)
2.3 Tumor Liquid Biopsy Kit Segment by Application
2.3.1 Solid Tumor
2.3.2 Blood Cancer
2.3.3 Tumor Liquid Biopsy Kit Sales by Application
2.3.3.1 Global Tumor Liquid Biopsy Kit Sale Market Share by Application (2021-2026)
2.3.3.2 Global Tumor Liquid Biopsy Kit Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Tumor Liquid Biopsy Kit Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Tumor Liquid Biopsy Kit Breakdown Data by Company
3.1.1 Global Tumor Liquid Biopsy Kit Annual Sales by Company (2021-2026)
3.1.2 Global Tumor Liquid Biopsy Kit Sales Market Share by Company (2021-2026)
3.2 Global Tumor Liquid Biopsy Kit Annual Revenue by Company (2021-2026)
3.2.1 Global Tumor Liquid Biopsy Kit Revenue by Company (2021-2026)
3.2.2 Global Tumor Liquid Biopsy Kit Revenue Market Share by Company (2021-2026)
3.3 Global Tumor Liquid Biopsy Kit Sale Price by Company
3.4 Key Manufacturers Tumor Liquid Biopsy Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tumor Liquid Biopsy Kit Product Location Distribution
3.4.2 Players Tumor Liquid Biopsy Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TUMOR LIQUID BIOPSY KIT BY GEOGRAPHIC REGION
4.1 World Historic Tumor Liquid Biopsy Kit Market Size by Geographic Region (2021-2026)
4.1.1 Global Tumor Liquid Biopsy Kit Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Tumor Liquid Biopsy Kit Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Tumor Liquid Biopsy Kit Market Size by Country/Region (2021-2026)
4.2.1 Global Tumor Liquid Biopsy Kit Annual Sales by Country/Region (2021-2026)
4.2.2 Global Tumor Liquid Biopsy Kit Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tumor Liquid Biopsy Kit Sales Growth
4.4 APAC Tumor Liquid Biopsy Kit Sales Growth
4.5 Europe Tumor Liquid Biopsy Kit Sales Growth
4.6 Middle East & Africa Tumor Liquid Biopsy Kit Sales Growth
5 AMERICAS
5.1 Americas Tumor Liquid Biopsy Kit Sales by Country
5.1.1 Americas Tumor Liquid Biopsy Kit Sales by Country (2021-2026)
5.1.2 Americas Tumor Liquid Biopsy Kit Revenue by Country (2021-2026)
5.2 Americas Tumor Liquid Biopsy Kit Sales by Type (2021-2026)
5.3 Americas Tumor Liquid Biopsy Kit Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Liquid Biopsy Kit Sales by Region
6.1.1 APAC Tumor Liquid Biopsy Kit Sales by Region (2021-2026)
6.1.2 APAC Tumor Liquid Biopsy Kit Revenue by Region (2021-2026)
6.2 APAC Tumor Liquid Biopsy Kit Sales by Type (2021-2026)
6.3 APAC Tumor Liquid Biopsy Kit Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tumor Liquid Biopsy Kit by Country
7.1.1 Europe Tumor Liquid Biopsy Kit Sales by Country (2021-2026)
7.1.2 Europe Tumor Liquid Biopsy Kit Revenue by Country (2021-2026)
7.2 Europe Tumor Liquid Biopsy Kit Sales by Type (2021-2026)
7.3 Europe Tumor Liquid Biopsy Kit Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor Liquid Biopsy Kit by Country
8.1.1 Middle East & Africa Tumor Liquid Biopsy Kit Sales by Country (2021-2026)
8.1.2 Middle East & Africa Tumor Liquid Biopsy Kit Revenue by Country (2021-2026)
8.2 Middle East & Africa Tumor Liquid Biopsy Kit Sales by Type (2021-2026)
8.3 Middle East & Africa Tumor Liquid Biopsy Kit Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tumor Liquid Biopsy Kit
10.3 Manufacturing Process Analysis of Tumor Liquid Biopsy Kit
10.4 Industry Chain Structure of Tumor Liquid Biopsy Kit
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tumor Liquid Biopsy Kit Distributors
11.3 Tumor Liquid Biopsy Kit Customer
12 WORLD FORECAST REVIEW FOR TUMOR LIQUID BIOPSY KIT BY GEOGRAPHIC REGION
12.1 Global Tumor Liquid Biopsy Kit Market Size Forecast by Region
12.1.1 Global Tumor Liquid Biopsy Kit Forecast by Region (2027-2032)
12.1.2 Global Tumor Liquid Biopsy Kit Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Tumor Liquid Biopsy Kit Forecast by Type (2027-2032)
12.7 Global Tumor Liquid Biopsy Kit Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Biocept
13.1.1 Biocept Company Information
13.1.2 Biocept Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.1.3 Biocept Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Biocept Main Business Overview
13.1.5 Biocept Latest Developments
13.2 Qiagen
13.2.1 Qiagen Company Information
13.2.2 Qiagen Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.2.3 Qiagen Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Qiagen Main Business Overview
13.2.5 Qiagen Latest Developments
13.3 Roche Diagnostics
13.3.1 Roche Diagnostics Company Information
13.3.2 Roche Diagnostics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.3.3 Roche Diagnostics Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Roche Diagnostics Main Business Overview
13.3.5 Roche Diagnostics Latest Developments
13.4 Bio-Rad Laboratories
13.4.1 Bio-Rad Laboratories Company Information
13.4.2 Bio-Rad Laboratories Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.4.3 Bio-Rad Laboratories Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bio-Rad Laboratories Main Business Overview
13.4.5 Bio-Rad Laboratories Latest Developments
13.5 Myriad Genetics
13.5.1 Myriad Genetics Company Information
13.5.2 Myriad Genetics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.5.3 Myriad Genetics Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Myriad Genetics Main Business Overview
13.5.5 Myriad Genetics Latest Developments
13.6 Menarini-Silicon Biosystems
13.6.1 Menarini-Silicon Biosystems Company Information
13.6.2 Menarini-Silicon Biosystems Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.6.3 Menarini-Silicon Biosystems Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Menarini-Silicon Biosystems Main Business Overview
13.6.5 Menarini-Silicon Biosystems Latest Developments
13.7 Cardiff Oncology
13.7.1 Cardiff Oncology Company Information
13.7.2 Cardiff Oncology Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.7.3 Cardiff Oncology Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cardiff Oncology Main Business Overview
13.7.5 Cardiff Oncology Latest Developments
13.8 Guardant Health
13.8.1 Guardant Health Company Information
13.8.2 Guardant Health Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.8.3 Guardant Health Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Guardant Health Main Business Overview
13.8.5 Guardant Health Latest Developments
13.9 Mdxhealth
13.9.1 Mdxhealth Company Information
13.9.2 Mdxhealth Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.9.3 Mdxhealth Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mdxhealth Main Business Overview
13.9.5 Mdxhealth Latest Developments
13.10 Genomic Health(Exact Sciences?
13.10.1 Genomic Health(Exact Sciences? Company Information
13.10.2 Genomic Health(Exact Sciences? Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.10.3 Genomic Health(Exact Sciences? Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Genomic Health(Exact Sciences? Main Business Overview
13.10.5 Genomic Health(Exact Sciences? Latest Developments
13.11 NeoGenomics
13.11.1 NeoGenomics Company Information
13.11.2 NeoGenomics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.11.3 NeoGenomics Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 NeoGenomics Main Business Overview
13.11.5 NeoGenomics Latest Developments
13.12 Thermo Fisher Scientific
13.12.1 Thermo Fisher Scientific Company Information
13.12.2 Thermo Fisher Scientific Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.12.3 Thermo Fisher Scientific Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Thermo Fisher Scientific Main Business Overview
13.12.5 Thermo Fisher Scientific Latest Developments
13.13 Illumina
13.13.1 Illumina Company Information
13.13.2 Illumina Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.13.3 Illumina Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Illumina Main Business Overview
13.13.5 Illumina Latest Developments
13.14 Amoy Diagnostics
13.14.1 Amoy Diagnostics Company Information
13.14.2 Amoy Diagnostics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.14.3 Amoy Diagnostics Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Amoy Diagnostics Main Business Overview
13.14.5 Amoy Diagnostics Latest Developments
13.15 Burning Rock Dx
13.15.1 Burning Rock Dx Company Information
13.15.2 Burning Rock Dx Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.15.3 Burning Rock Dx Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Burning Rock Dx Main Business Overview
13.15.5 Burning Rock Dx Latest Developments
13.16 Genetron
13.16.1 Genetron Company Information
13.16.2 Genetron Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.16.3 Genetron Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Genetron Main Business Overview
13.16.5 Genetron Latest Developments
13.17 BGI
13.17.1 BGI Company Information
13.17.2 BGI Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.17.3 BGI Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 BGI Main Business Overview
13.17.5 BGI Latest Developments
13.18 Novogene
13.18.1 Novogene Company Information
13.18.2 Novogene Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.18.3 Novogene Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Novogene Main Business Overview
13.18.5 Novogene Latest Developments
13.19 Agena Bioscience(Mesa Labs, Inc.)
13.19.1 Agena Bioscience(Mesa Labs, Inc.) Company Information
13.19.2 Agena Bioscience(Mesa Labs, Inc.) Tumor Liquid Biopsy Kit Product Portfolios and Specifications
13.19.3 Agena Bioscience(Mesa Labs, Inc.) Tumor Liquid Biopsy Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Agena Bioscience(Mesa Labs, Inc.) Main Business Overview
13.19.5 Agena Bioscience(Mesa Labs, Inc.) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tumor Liquid Biopsy Kit Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Tumor Liquid Biopsy Kit Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Samples
Table 4. Major Players of Urine Samples
Table 5. Major Players of NGS
Table 6. Major Players of Others
Table 7. Global Tumor Liquid Biopsy Kit Sales by Type (2021-2026) & (K Units)
Table 8. Global Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
Table 9. Global Tumor Liquid Biopsy Kit Revenue by Type (2021-2026) & ($ million)
Table 10. Global Tumor Liquid Biopsy Kit Revenue Market Share by Type (2021-2026)
Table 11. Global Tumor Liquid Biopsy Kit Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Tumor Liquid Biopsy Kit Sale by Application (2021-2026) & (K Units)
Table 13. Global Tumor Liquid Biopsy Kit Sale Market Share by Application (2021-2026)
Table 14. Global Tumor Liquid Biopsy Kit Revenue by Application (2021-2026) & ($ million)
Table 15. Global Tumor Liquid Biopsy Kit Revenue Market Share by Application (2021-2026)
Table 16. Global Tumor Liquid Biopsy Kit Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Tumor Liquid Biopsy Kit Sales by Company (2021-2026) & (K Units)
Table 18. Global Tumor Liquid Biopsy Kit Sales Market Share by Company (2021-2026)
Table 19. Global Tumor Liquid Biopsy Kit Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Tumor Liquid Biopsy Kit Revenue Market Share by Company (2021-2026)
Table 21. Global Tumor Liquid Biopsy Kit Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Tumor Liquid Biopsy Kit Producing Area Distribution and Sales Area
Table 23. Players Tumor Liquid Biopsy Kit Products Offered
Table 24. Tumor Liquid Biopsy Kit Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Tumor Liquid Biopsy Kit Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Tumor Liquid Biopsy Kit Sales Market Share Geographic Region (2021-2026)
Table 29. Global Tumor Liquid Biopsy Kit Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Tumor Liquid Biopsy Kit Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Tumor Liquid Biopsy Kit Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Tumor Liquid Biopsy Kit Sales Market Share by Country/Region (2021-2026)
Table 33. Global Tumor Liquid Biopsy Kit Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Tumor Liquid Biopsy Kit Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Tumor Liquid Biopsy Kit Sales by Country (2021-2026) & (K Units)
Table 36. Americas Tumor Liquid Biopsy Kit Sales Market Share by Country (2021-2026)
Table 37. Americas Tumor Liquid Biopsy Kit Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Tumor Liquid Biopsy Kit Sales by Type (2021-2026) & (K Units)
Table 39. Americas Tumor Liquid Biopsy Kit Sales by Application (2021-2026) & (K Units)
Table 40. APAC Tumor Liquid Biopsy Kit Sales by Region (2021-2026) & (K Units)
Table 41. APAC Tumor Liquid Biopsy Kit Sales Market Share by Region (2021-2026)
Table 42. APAC Tumor Liquid Biopsy Kit Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Tumor Liquid Biopsy Kit Sales by Type (2021-2026) & (K Units)
Table 44. APAC Tumor Liquid Biopsy Kit Sales by Application (2021-2026) & (K Units)
Table 45. Europe Tumor Liquid Biopsy Kit Sales by Country (2021-2026) & (K Units)
Table 46. Europe Tumor Liquid Biopsy Kit Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Tumor Liquid Biopsy Kit Sales by Type (2021-2026) & (K Units)
Table 48. Europe Tumor Liquid Biopsy Kit Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Tumor Liquid Biopsy Kit Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Tumor Liquid Biopsy Kit Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Tumor Liquid Biopsy Kit Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Tumor Liquid Biopsy Kit Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Tumor Liquid Biopsy Kit
Table 54. Key Market Challenges & Risks of Tumor Liquid Biopsy Kit
Table 55. Key Industry Trends of Tumor Liquid Biopsy Kit
Table 56. Tumor Liquid Biopsy Kit Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Tumor Liquid Biopsy Kit Distributors List
Table 59. Tumor Liquid Biopsy Kit Customer List
Table 60. Global Tumor Liquid Biopsy Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Tumor Liquid Biopsy Kit Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Tumor Liquid Biopsy Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Tumor Liquid Biopsy Kit Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Tumor Liquid Biopsy Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Tumor Liquid Biopsy Kit Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Tumor Liquid Biopsy Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Tumor Liquid Biopsy Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Tumor Liquid Biopsy Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Tumor Liquid Biopsy Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Tumor Liquid Biopsy Kit Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Tumor Liquid Biopsy Kit Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Tumor Liquid Biopsy Kit Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Tumor Liquid Biopsy Kit Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Biocept Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 75. Biocept Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 76. Biocept Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Biocept Main Business
Table 78. Biocept Latest Developments
Table 79. Qiagen Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 80. Qiagen Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 81. Qiagen Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Qiagen Main Business
Table 83. Qiagen Latest Developments
Table 84. Roche Diagnostics Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 85. Roche Diagnostics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 86. Roche Diagnostics Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Roche Diagnostics Main Business
Table 88. Roche Diagnostics Latest Developments
Table 89. Bio-Rad Laboratories Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 90. Bio-Rad Laboratories Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 91. Bio-Rad Laboratories Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Bio-Rad Laboratories Main Business
Table 93. Bio-Rad Laboratories Latest Developments
Table 94. Myriad Genetics Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 95. Myriad Genetics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 96. Myriad Genetics Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Myriad Genetics Main Business
Table 98. Myriad Genetics Latest Developments
Table 99. Menarini-Silicon Biosystems Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 100. Menarini-Silicon Biosystems Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 101. Menarini-Silicon Biosystems Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Menarini-Silicon Biosystems Main Business
Table 103. Menarini-Silicon Biosystems Latest Developments
Table 104. Cardiff Oncology Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 105. Cardiff Oncology Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 106. Cardiff Oncology Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Cardiff Oncology Main Business
Table 108. Cardiff Oncology Latest Developments
Table 109. Guardant Health Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 110. Guardant Health Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 111. Guardant Health Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Guardant Health Main Business
Table 113. Guardant Health Latest Developments
Table 114. Mdxhealth Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 115. Mdxhealth Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 116. Mdxhealth Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Mdxhealth Main Business
Table 118. Mdxhealth Latest Developments
Table 119. Genomic Health(Exact Sciences? Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 120. Genomic Health(Exact Sciences? Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 121. Genomic Health(Exact Sciences? Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Genomic Health(Exact Sciences? Main Business
Table 123. Genomic Health(Exact Sciences? Latest Developments
Table 124. NeoGenomics Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 125. NeoGenomics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 126. NeoGenomics Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. NeoGenomics Main Business
Table 128. NeoGenomics Latest Developments
Table 129. Thermo Fisher Scientific Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 130. Thermo Fisher Scientific Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 131. Thermo Fisher Scientific Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Thermo Fisher Scientific Main Business
Table 133. Thermo Fisher Scientific Latest Developments
Table 134. Illumina Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 135. Illumina Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 136. Illumina Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Illumina Main Business
Table 138. Illumina Latest Developments
Table 139. Amoy Diagnostics Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 140. Amoy Diagnostics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 141. Amoy Diagnostics Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Amoy Diagnostics Main Business
Table 143. Amoy Diagnostics Latest Developments
Table 144. Burning Rock Dx Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 145. Burning Rock Dx Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 146. Burning Rock Dx Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Burning Rock Dx Main Business
Table 148. Burning Rock Dx Latest Developments
Table 149. Genetron Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 150. Genetron Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 151. Genetron Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Genetron Main Business
Table 153. Genetron Latest Developments
Table 154. BGI Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 155. BGI Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 156. BGI Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. BGI Main Business
Table 158. BGI Latest Developments
Table 159. Novogene Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 160. Novogene Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 161. Novogene Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Novogene Main Business
Table 163. Novogene Latest Developments
Table 164. Agena Bioscience(Mesa Labs, Inc.) Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 165. Agena Bioscience(Mesa Labs, Inc.) Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 166. Agena Bioscience(Mesa Labs, Inc.) Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Agena Bioscience(Mesa Labs, Inc.) Main Business
Table 168. Agena Bioscience(Mesa Labs, Inc.) Latest Developments
Table 1. Tumor Liquid Biopsy Kit Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Tumor Liquid Biopsy Kit Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Samples
Table 4. Major Players of Urine Samples
Table 5. Major Players of NGS
Table 6. Major Players of Others
Table 7. Global Tumor Liquid Biopsy Kit Sales by Type (2021-2026) & (K Units)
Table 8. Global Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
Table 9. Global Tumor Liquid Biopsy Kit Revenue by Type (2021-2026) & ($ million)
Table 10. Global Tumor Liquid Biopsy Kit Revenue Market Share by Type (2021-2026)
Table 11. Global Tumor Liquid Biopsy Kit Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Tumor Liquid Biopsy Kit Sale by Application (2021-2026) & (K Units)
Table 13. Global Tumor Liquid Biopsy Kit Sale Market Share by Application (2021-2026)
Table 14. Global Tumor Liquid Biopsy Kit Revenue by Application (2021-2026) & ($ million)
Table 15. Global Tumor Liquid Biopsy Kit Revenue Market Share by Application (2021-2026)
Table 16. Global Tumor Liquid Biopsy Kit Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Tumor Liquid Biopsy Kit Sales by Company (2021-2026) & (K Units)
Table 18. Global Tumor Liquid Biopsy Kit Sales Market Share by Company (2021-2026)
Table 19. Global Tumor Liquid Biopsy Kit Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Tumor Liquid Biopsy Kit Revenue Market Share by Company (2021-2026)
Table 21. Global Tumor Liquid Biopsy Kit Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Tumor Liquid Biopsy Kit Producing Area Distribution and Sales Area
Table 23. Players Tumor Liquid Biopsy Kit Products Offered
Table 24. Tumor Liquid Biopsy Kit Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Tumor Liquid Biopsy Kit Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Tumor Liquid Biopsy Kit Sales Market Share Geographic Region (2021-2026)
Table 29. Global Tumor Liquid Biopsy Kit Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Tumor Liquid Biopsy Kit Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Tumor Liquid Biopsy Kit Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Tumor Liquid Biopsy Kit Sales Market Share by Country/Region (2021-2026)
Table 33. Global Tumor Liquid Biopsy Kit Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Tumor Liquid Biopsy Kit Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Tumor Liquid Biopsy Kit Sales by Country (2021-2026) & (K Units)
Table 36. Americas Tumor Liquid Biopsy Kit Sales Market Share by Country (2021-2026)
Table 37. Americas Tumor Liquid Biopsy Kit Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Tumor Liquid Biopsy Kit Sales by Type (2021-2026) & (K Units)
Table 39. Americas Tumor Liquid Biopsy Kit Sales by Application (2021-2026) & (K Units)
Table 40. APAC Tumor Liquid Biopsy Kit Sales by Region (2021-2026) & (K Units)
Table 41. APAC Tumor Liquid Biopsy Kit Sales Market Share by Region (2021-2026)
Table 42. APAC Tumor Liquid Biopsy Kit Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Tumor Liquid Biopsy Kit Sales by Type (2021-2026) & (K Units)
Table 44. APAC Tumor Liquid Biopsy Kit Sales by Application (2021-2026) & (K Units)
Table 45. Europe Tumor Liquid Biopsy Kit Sales by Country (2021-2026) & (K Units)
Table 46. Europe Tumor Liquid Biopsy Kit Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Tumor Liquid Biopsy Kit Sales by Type (2021-2026) & (K Units)
Table 48. Europe Tumor Liquid Biopsy Kit Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Tumor Liquid Biopsy Kit Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Tumor Liquid Biopsy Kit Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Tumor Liquid Biopsy Kit Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Tumor Liquid Biopsy Kit Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Tumor Liquid Biopsy Kit
Table 54. Key Market Challenges & Risks of Tumor Liquid Biopsy Kit
Table 55. Key Industry Trends of Tumor Liquid Biopsy Kit
Table 56. Tumor Liquid Biopsy Kit Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Tumor Liquid Biopsy Kit Distributors List
Table 59. Tumor Liquid Biopsy Kit Customer List
Table 60. Global Tumor Liquid Biopsy Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Tumor Liquid Biopsy Kit Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Tumor Liquid Biopsy Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Tumor Liquid Biopsy Kit Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Tumor Liquid Biopsy Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Tumor Liquid Biopsy Kit Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Tumor Liquid Biopsy Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Tumor Liquid Biopsy Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Tumor Liquid Biopsy Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Tumor Liquid Biopsy Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Tumor Liquid Biopsy Kit Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Tumor Liquid Biopsy Kit Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Tumor Liquid Biopsy Kit Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Tumor Liquid Biopsy Kit Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Biocept Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 75. Biocept Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 76. Biocept Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Biocept Main Business
Table 78. Biocept Latest Developments
Table 79. Qiagen Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 80. Qiagen Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 81. Qiagen Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Qiagen Main Business
Table 83. Qiagen Latest Developments
Table 84. Roche Diagnostics Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 85. Roche Diagnostics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 86. Roche Diagnostics Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Roche Diagnostics Main Business
Table 88. Roche Diagnostics Latest Developments
Table 89. Bio-Rad Laboratories Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 90. Bio-Rad Laboratories Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 91. Bio-Rad Laboratories Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Bio-Rad Laboratories Main Business
Table 93. Bio-Rad Laboratories Latest Developments
Table 94. Myriad Genetics Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 95. Myriad Genetics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 96. Myriad Genetics Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Myriad Genetics Main Business
Table 98. Myriad Genetics Latest Developments
Table 99. Menarini-Silicon Biosystems Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 100. Menarini-Silicon Biosystems Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 101. Menarini-Silicon Biosystems Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Menarini-Silicon Biosystems Main Business
Table 103. Menarini-Silicon Biosystems Latest Developments
Table 104. Cardiff Oncology Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 105. Cardiff Oncology Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 106. Cardiff Oncology Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Cardiff Oncology Main Business
Table 108. Cardiff Oncology Latest Developments
Table 109. Guardant Health Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 110. Guardant Health Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 111. Guardant Health Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Guardant Health Main Business
Table 113. Guardant Health Latest Developments
Table 114. Mdxhealth Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 115. Mdxhealth Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 116. Mdxhealth Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Mdxhealth Main Business
Table 118. Mdxhealth Latest Developments
Table 119. Genomic Health(Exact Sciences? Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 120. Genomic Health(Exact Sciences? Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 121. Genomic Health(Exact Sciences? Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Genomic Health(Exact Sciences? Main Business
Table 123. Genomic Health(Exact Sciences? Latest Developments
Table 124. NeoGenomics Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 125. NeoGenomics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 126. NeoGenomics Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. NeoGenomics Main Business
Table 128. NeoGenomics Latest Developments
Table 129. Thermo Fisher Scientific Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 130. Thermo Fisher Scientific Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 131. Thermo Fisher Scientific Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Thermo Fisher Scientific Main Business
Table 133. Thermo Fisher Scientific Latest Developments
Table 134. Illumina Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 135. Illumina Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 136. Illumina Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Illumina Main Business
Table 138. Illumina Latest Developments
Table 139. Amoy Diagnostics Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 140. Amoy Diagnostics Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 141. Amoy Diagnostics Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Amoy Diagnostics Main Business
Table 143. Amoy Diagnostics Latest Developments
Table 144. Burning Rock Dx Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 145. Burning Rock Dx Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 146. Burning Rock Dx Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Burning Rock Dx Main Business
Table 148. Burning Rock Dx Latest Developments
Table 149. Genetron Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 150. Genetron Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 151. Genetron Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Genetron Main Business
Table 153. Genetron Latest Developments
Table 154. BGI Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 155. BGI Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 156. BGI Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. BGI Main Business
Table 158. BGI Latest Developments
Table 159. Novogene Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 160. Novogene Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 161. Novogene Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Novogene Main Business
Table 163. Novogene Latest Developments
Table 164. Agena Bioscience(Mesa Labs, Inc.) Basic Information, Tumor Liquid Biopsy Kit Manufacturing Base, Sales Area and Its Competitors
Table 165. Agena Bioscience(Mesa Labs, Inc.) Tumor Liquid Biopsy Kit Product Portfolios and Specifications
Table 166. Agena Bioscience(Mesa Labs, Inc.) Tumor Liquid Biopsy Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Agena Bioscience(Mesa Labs, Inc.) Main Business
Table 168. Agena Bioscience(Mesa Labs, Inc.) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tumor Liquid Biopsy Kit
Figure 2. Tumor Liquid Biopsy Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tumor Liquid Biopsy Kit Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Tumor Liquid Biopsy Kit Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Tumor Liquid Biopsy Kit Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Tumor Liquid Biopsy Kit Sales Market Share by Country/Region (2025)
Figure 10. Tumor Liquid Biopsy Kit Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Blood Samples
Figure 12. Product Picture of Urine Samples
Figure 13. Product Picture of NGS
Figure 14. Product Picture of Others
Figure 15. Global Tumor Liquid Biopsy Kit Sales Market Share by Type in 2026
Figure 16. Global Tumor Liquid Biopsy Kit Revenue Market Share by Type (2021-2026)
Figure 17. Tumor Liquid Biopsy Kit Consumed in Solid Tumor
Figure 18. Global Tumor Liquid Biopsy Kit Market: Solid Tumor (2021-2026) & (K Units)
Figure 19. Tumor Liquid Biopsy Kit Consumed in Blood Cancer
Figure 20. Global Tumor Liquid Biopsy Kit Market: Blood Cancer (2021-2026) & (K Units)
Figure 21. Global Tumor Liquid Biopsy Kit Sale Market Share by Application (2025)
Figure 22. Global Tumor Liquid Biopsy Kit Revenue Market Share by Application in 2026
Figure 23. Tumor Liquid Biopsy Kit Sales by Company in 2026 (K Units)
Figure 24. Global Tumor Liquid Biopsy Kit Sales Market Share by Company in 2026
Figure 25. Tumor Liquid Biopsy Kit Revenue by Company in 2026 ($ millions)
Figure 26. Global Tumor Liquid Biopsy Kit Revenue Market Share by Company in 2026
Figure 27. Global Tumor Liquid Biopsy Kit Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Tumor Liquid Biopsy Kit Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Tumor Liquid Biopsy Kit Sales 2021-2026 (K Units)
Figure 30. Americas Tumor Liquid Biopsy Kit Revenue 2021-2026 ($ millions)
Figure 31. APAC Tumor Liquid Biopsy Kit Sales 2021-2026 (K Units)
Figure 32. APAC Tumor Liquid Biopsy Kit Revenue 2021-2026 ($ millions)
Figure 33. Europe Tumor Liquid Biopsy Kit Sales 2021-2026 (K Units)
Figure 34. Europe Tumor Liquid Biopsy Kit Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Tumor Liquid Biopsy Kit Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Tumor Liquid Biopsy Kit Revenue 2021-2026 ($ millions)
Figure 37. Americas Tumor Liquid Biopsy Kit Sales Market Share by Country in 2026
Figure 38. Americas Tumor Liquid Biopsy Kit Revenue Market Share by Country (2021-2026)
Figure 39. Americas Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
Figure 40. Americas Tumor Liquid Biopsy Kit Sales Market Share by Application (2021-2026)
Figure 41. United States Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Tumor Liquid Biopsy Kit Sales Market Share by Region in 2026
Figure 46. APAC Tumor Liquid Biopsy Kit Revenue Market Share by Region (2021-2026)
Figure 47. APAC Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
Figure 48. APAC Tumor Liquid Biopsy Kit Sales Market Share by Application (2021-2026)
Figure 49. China Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 53. India Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Tumor Liquid Biopsy Kit Sales Market Share by Country in 2026
Figure 57. Europe Tumor Liquid Biopsy Kit Revenue Market Share by Country (2021-2026)
Figure 58. Europe Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
Figure 59. Europe Tumor Liquid Biopsy Kit Sales Market Share by Application (2021-2026)
Figure 60. Germany Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 61. France Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Tumor Liquid Biopsy Kit Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Tumor Liquid Biopsy Kit Sales Market Share by Application (2021-2026)
Figure 68. Egypt Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Tumor Liquid Biopsy Kit in 2026
Figure 74. Manufacturing Process Analysis of Tumor Liquid Biopsy Kit
Figure 75. Industry Chain Structure of Tumor Liquid Biopsy Kit
Figure 76. Channels of Distribution
Figure 77. Global Tumor Liquid Biopsy Kit Sales Market Forecast by Region (2027-2032)
Figure 78. Global Tumor Liquid Biopsy Kit Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Tumor Liquid Biopsy Kit Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Tumor Liquid Biopsy Kit Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Tumor Liquid Biopsy Kit Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Tumor Liquid Biopsy Kit Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Tumor Liquid Biopsy Kit
Figure 2. Tumor Liquid Biopsy Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tumor Liquid Biopsy Kit Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Tumor Liquid Biopsy Kit Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Tumor Liquid Biopsy Kit Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Tumor Liquid Biopsy Kit Sales Market Share by Country/Region (2025)
Figure 10. Tumor Liquid Biopsy Kit Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Blood Samples
Figure 12. Product Picture of Urine Samples
Figure 13. Product Picture of NGS
Figure 14. Product Picture of Others
Figure 15. Global Tumor Liquid Biopsy Kit Sales Market Share by Type in 2026
Figure 16. Global Tumor Liquid Biopsy Kit Revenue Market Share by Type (2021-2026)
Figure 17. Tumor Liquid Biopsy Kit Consumed in Solid Tumor
Figure 18. Global Tumor Liquid Biopsy Kit Market: Solid Tumor (2021-2026) & (K Units)
Figure 19. Tumor Liquid Biopsy Kit Consumed in Blood Cancer
Figure 20. Global Tumor Liquid Biopsy Kit Market: Blood Cancer (2021-2026) & (K Units)
Figure 21. Global Tumor Liquid Biopsy Kit Sale Market Share by Application (2025)
Figure 22. Global Tumor Liquid Biopsy Kit Revenue Market Share by Application in 2026
Figure 23. Tumor Liquid Biopsy Kit Sales by Company in 2026 (K Units)
Figure 24. Global Tumor Liquid Biopsy Kit Sales Market Share by Company in 2026
Figure 25. Tumor Liquid Biopsy Kit Revenue by Company in 2026 ($ millions)
Figure 26. Global Tumor Liquid Biopsy Kit Revenue Market Share by Company in 2026
Figure 27. Global Tumor Liquid Biopsy Kit Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Tumor Liquid Biopsy Kit Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Tumor Liquid Biopsy Kit Sales 2021-2026 (K Units)
Figure 30. Americas Tumor Liquid Biopsy Kit Revenue 2021-2026 ($ millions)
Figure 31. APAC Tumor Liquid Biopsy Kit Sales 2021-2026 (K Units)
Figure 32. APAC Tumor Liquid Biopsy Kit Revenue 2021-2026 ($ millions)
Figure 33. Europe Tumor Liquid Biopsy Kit Sales 2021-2026 (K Units)
Figure 34. Europe Tumor Liquid Biopsy Kit Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Tumor Liquid Biopsy Kit Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Tumor Liquid Biopsy Kit Revenue 2021-2026 ($ millions)
Figure 37. Americas Tumor Liquid Biopsy Kit Sales Market Share by Country in 2026
Figure 38. Americas Tumor Liquid Biopsy Kit Revenue Market Share by Country (2021-2026)
Figure 39. Americas Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
Figure 40. Americas Tumor Liquid Biopsy Kit Sales Market Share by Application (2021-2026)
Figure 41. United States Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Tumor Liquid Biopsy Kit Sales Market Share by Region in 2026
Figure 46. APAC Tumor Liquid Biopsy Kit Revenue Market Share by Region (2021-2026)
Figure 47. APAC Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
Figure 48. APAC Tumor Liquid Biopsy Kit Sales Market Share by Application (2021-2026)
Figure 49. China Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 53. India Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Tumor Liquid Biopsy Kit Sales Market Share by Country in 2026
Figure 57. Europe Tumor Liquid Biopsy Kit Revenue Market Share by Country (2021-2026)
Figure 58. Europe Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
Figure 59. Europe Tumor Liquid Biopsy Kit Sales Market Share by Application (2021-2026)
Figure 60. Germany Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 61. France Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Tumor Liquid Biopsy Kit Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Tumor Liquid Biopsy Kit Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Tumor Liquid Biopsy Kit Sales Market Share by Application (2021-2026)
Figure 68. Egypt Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Tumor Liquid Biopsy Kit Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Tumor Liquid Biopsy Kit in 2026
Figure 74. Manufacturing Process Analysis of Tumor Liquid Biopsy Kit
Figure 75. Industry Chain Structure of Tumor Liquid Biopsy Kit
Figure 76. Channels of Distribution
Figure 77. Global Tumor Liquid Biopsy Kit Sales Market Forecast by Region (2027-2032)
Figure 78. Global Tumor Liquid Biopsy Kit Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Tumor Liquid Biopsy Kit Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Tumor Liquid Biopsy Kit Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Tumor Liquid Biopsy Kit Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Tumor Liquid Biopsy Kit Revenue Market Share Forecast by Application (2027-2032)
